These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Long-term management of erythrodermic psoriasis with anti-TNF agents.
    Author: Romero-Maté A, García-Donoso C, Martinez-Morán C, Hernández-Núñez A, Borbujo J.
    Journal: Dermatol Online J; 2010 Jun 15; 16(6):15. PubMed ID: 20579470.
    Abstract:
    Erythrodermic psoriasis is a chronic condition that is difficult to treat. Biological agents offer a new alternative, but there are no controlled trials to support their use; there are a few reports of patients treated with these agents, but often only with short term results. We report a 68-year-old man with erythrodermic psoriasis and ankylosing spondylitis, treated with infliximab for 48 weeks and then low-dose etanercept monotherapy for 34 additional months. Excellent results were obtained for both conditions without significant side effects. We think etanercept can be a good therapeutic option for long-term control of erythrodermic psoriasis.
    [Abstract] [Full Text] [Related] [New Search]